Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

2. Neurocrine Biosciences (NBIX)

14.1% sales growth and 42.19% return on equity

Neurocrine Biosciences, Inc., a biopharmaceutical company, discovers, develops, and markets pharmaceutical products for the treatment of neurological, endocrine, and psychiatric-based diseases and disorders in the United States.

Neurocrine Biosciences’s sales growth this year is expected to be 8.4% and 26.4% for next year.

Year-on-year quarterly revenue growth declined by 0.2%, now sitting on 1.05B for the twelve trailing months.

Neurocrine Biosciences’s sales growth is a negative 0% for the present quarter and 14.1% for the next. The company’s growth estimates for the present quarter and the next is a negative 39.5% and 191.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 42.19%.

Volatility

Neurocrine Biosciences’s last day, last week, and last month’s current volatility was 0.77%, 1.09%, and 1.15%, respectively.

Neurocrine Biosciences’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.78% (day), 4.64% (last week), and 3.33% (last month), respectively.

Neurocrine Biosciences’s Stock Yearly Top and Bottom Value

Neurocrine Biosciences’s stock is valued at $92.15 at 23:22 EST, way under its 52-week high of $136.26 and higher than its 52-week low of $86.02.

Neurocrine Biosciences’s Moving Average

Neurocrine Biosciences’s value is under its 50-day moving average of $94.64 and under its 200-day moving average of $99.50.

3. Saia (SAIA)

17.3% sales growth and 16.03% return on equity

Saia, Inc., through its subsidiaries, operates as a transportation company in North America.

Saia’s sales growth this year is expected to be 16.6% and 8% for next year.

Year-on-year quarterly revenue growth grew by 8.4%, now sitting on 1.86B for the twelve trailing months.

Saia’s sales growth for the next quarter is 17.3%. The company’s growth estimates for the present quarter and the next is 84.1% and 26.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.03%.

Volatility

Saia’s last day, last week, and last month’s current volatility was 6.41%, 2.96%, and 1.63%, respectively.

Saia’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 6.24% (day), 4.21% (last week), and 3.39% (last month), respectively.

Saia’s Stock Yearly Top and Bottom Value

Saia’s stock is valued at $228.27 at 23:22 EST, under its 52-week high of $243.36 and way above its 52-week low of $69.03.

Saia’s Moving Average

Saia’s value is above its 50-day moving average of $216.25 and way above its 200-day moving average of $179.84.

4. Yamana Gold (AUY)

12.3% sales growth and 4.45% return on equity

Yamana Gold Inc., a precious metals producer, explores for and produces gold and silver ores.

Yamana Gold’s sales growth this year is anticipated to be 8.6% and 6.7% for next year.

Year-on-year quarterly revenue growth grew by 18.4%, now sitting on 1.63B for the twelve trailing months.

Yamana Gold’s sales growth for the next quarter is 12.3%. The company’s growth estimates for the ongoing quarter and the next is 166.7% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.45%.

Volatility

Yamana Gold’s last day, last week, and last month’s current volatility was 0.80%, 1.04%, and 1.89%, respectively.

Yamana Gold’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.23% (day), 2.98% (last week), and 3.12% (last month), respectively.

Yamana Gold’s Stock Yearly Top and Bottom Value

Yamana Gold’s stock is valued at $5.12 at 23:22 EST, way below its 52-week high of $7.02 and way higher than its 52-week low of $3.18.

Yamana Gold’s Moving Average

Yamana Gold’s value is way above its 50-day moving average of $4.42 and below its 200-day moving average of $5.24.

Previous days news about Yamana Gold(AUY)

According to Business Insider on Monday, 10 May, "Pursuant to the deferred payment payable to Yamana Gold Inc. and based on the CAD $/US$ daily exchange rate published by the Bank of Canada on May10, 2021, 13,508,037 common shares would be issuable should the conversion option be exercised on such date.", "Adjusted net income and adjusted net income per share are calculated by removing the effects of the non-cash cost of sales related to the gold prepay loan, the non-cash change in fair value of the conversion option for the Deferred Payment to the Yamana Gold Inc. and the non-cash change in fair value of gold prepay loan and the deferred income tax recovery related to stream interests subject to the RTO Transaction. "

5. Luxfer Holdings PLC (LXFR)

5.9% sales growth and 12.73% return on equity

Luxfer Holdings PLC, a materials technology company, designs, manufactures, and supplies high-performance materials, components, and high-pressure gas cylinders for transportation, defense and emergency response, healthcare, and general industrial end-market applications.

Luxfer Holdings PLC’s sales growth this year is expected to be 13.3% and 7.5% for next year.

Year-on-year quarterly revenue growth declined by 3.6%, now sitting on 321.6M for the twelve trailing months.

Luxfer Holdings PLC’s sales growth for the next quarter is 5.9%. The company’s growth estimates for the current quarter and the next is 70.6% and 24%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.73%.

Volatility

Luxfer Holdings PLC’s last day, last week, and last month’s current volatility was 0.52%, 0.79%, and 1.58%, respectively.

Luxfer Holdings PLC’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.41% (day), 2.57% (last week), and 3.27% (last month), respectively.

Luxfer Holdings PLC’s Stock Yearly Top and Bottom Value

Luxfer Holdings PLC’s stock is valued at $22.44 at 23:22 EST, below its 52-week high of $23.09 and way above its 52-week low of $11.42.

Luxfer Holdings PLC’s Moving Average

Luxfer Holdings PLC’s worth is higher than its 50-day moving average of $20.94 and way above its 200-day moving average of $17.89.

6. RE/MAX Holdings (RMAX)

46% sales growth and 18.97% return on equity

RE/MAX Holdings, Inc. operates as a franchisor of real estate and mortgage brokerage services in the United States, Canada, and internationally.

RE/MAX Holdings’s sales growth this year is anticipated to be 13.4% and 4.5% for next year.

Year-on-year quarterly revenue growth grew by 6.2%, now sitting on 266M for the twelve trailing months.

RE/MAX Holdings’s sales growth for the next quarter is 46%. The company’s growth estimates for the ongoing quarter and the next is 15.4% and 52.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.97%.

Volatility

RE/MAX Holdings’s last day, last week, and last month’s current volatility was 0.75%, 0.79%, and 1.62%, respectively.

RE/MAX Holdings’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.43% (day), 2.70% (last week), and 3.25% (last month), respectively.

RE/MAX Holdings’s Stock Yearly Top and Bottom Value

RE/MAX Holdings’s stock is valued at $36.06 at 23:22 EST, way under its 52-week high of $43.85 and way above its 52-week low of $19.60.

RE/MAX Holdings’s Moving Average

RE/MAX Holdings’s worth is under its 50-day moving average of $39.98 and below its 200-day moving average of $36.30.

Previous days news about RE/MAX Holdings(RMAX)

According to Business Insider on Monday, 10 May, "About the RE/MAX NetworkAs one of the leading global real estate franchisors, RE/MAX, LLC is a subsidiary of RE/MAX Holdings (NYSE: RMAX) with nearly 140,000 agents in more than 110 countries and territories. "

7. East West Bancorp (EWBC)

8.3% sales growth and 12.33% return on equity

East West Bancorp, Inc. operates as the bank holding company for East West Bank that provides a range of personal and commercial banking services to businesses and individuals in the United States and Greater China.

East West Bancorp’s sales growth this year is anticipated to be 9.8% and 5.1% for next year.

Year-on-year quarterly revenue growth grew by 23.2%, now sitting on 1.41B for the twelve trailing months.

East West Bancorp’s sales growth for the next quarter is 8.3%. The company’s growth estimates for the current quarter and the next is 98.6% and 25%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.33%.

Volatility

East West Bancorp’s last day, last week, and last month’s current volatility was 1.23%, 0.94%, and 1.49%, respectively.

East West Bancorp’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.27% (day), 3.45% (last week), and 3.21% (last month), respectively.

East West Bancorp’s Stock Yearly Top and Bottom Value

East West Bancorp’s stock is valued at $76.64 at 23:22 EST, under its 52-week high of $82.53 and way higher than its 52-week low of $29.53.

East West Bancorp’s Moving Average

East West Bancorp’s value is higher than its 50-day moving average of $75.00 and way above its 200-day moving average of $61.36.

8. Cross Country Healthcare (CCRN)

48.9% sales growth and 5.42% return on equity

Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States.

Cross Country Healthcare’s sales growth this year is anticipated to be 34.9% and a negative 17.2% for next year.

Year-on-year quarterly revenue growth grew by 56.7%, now sitting on 955.59M for the twelve trailing months.

Cross Country Healthcare’s sales growth for the next quarter is 48.9%. The company’s growth estimates for the ongoing quarter and the next is 143.8% and 83.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.42%.

Volatility

Cross Country Healthcare’s last day, last week, and last month’s current volatility was 3.13%, 5.13%, and 2.56%, respectively.

Cross Country Healthcare’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.33% (day), 8.94% (last week), and 5.43% (last month), respectively.

Cross Country Healthcare’s Stock Yearly Top and Bottom Value

Cross Country Healthcare’s stock is valued at $16.63 at 23:22 EST, under its 52-week high of $17.39 and way above its 52-week low of $4.50.

Cross Country Healthcare’s Moving Average

Cross Country Healthcare’s worth is way higher than its 50-day moving average of $13.25 and way higher than its 200-day moving average of $10.45.

LEAVE A REPLY

Please enter your comment!
Please enter your name here